2017
DOI: 10.1590/s1984-29612017005 View full text |Buy / Rent full text
|
|

Abstract: This study evaluated a recombinant aquaporin 1 protein of Rhipicephalus (Boophilus) microplus (RmAQP1) as antigen in a vaccine against R. sanguineus. Five dogs were immunized with RmAQP1 (10 µg) + adjuvant (Montanide) (G1), and five were inoculated with adjuvant only (G2), three times. Twenty-one days after the last immunization, animals of both groups were challenged with R. sanguineus larvae, nymphs and adults, and their biotic potential was compared. Blood samples were collected before each immunization and… Show more

Help me understand this report

Search citation statements

Order By: Relevance
Select...
1
8
0

Publication Types

Select...

Relationship

0
0

Authors

Journals